Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid UsersLynn R. Webster, Sabrina Ciric, Franklin K. Johnson et al.|Drugs in R&D|2011Cited by 43
The Abuse Potential of Remoxy<sup>®</sup>, an Extended-Release Formulation of Oxycodone, Compared with Immediate- and Extended-Release OxycodoneBeatrice Setnik, Lynn R. Webster, Carl L. Roland et al.|Pain Medicine|2011Cited by 42
Effect of difelikefalin, a selective kappa opioid receptor agonist, on respiratory depression<b>:</b>A randomized, double‐blind, placebo‐controlled trialEugene R. Viscusi, Sukirti Bagal, Marc C. Torjman et al.|Clinical and Translational Science|2021Cited by 34
Assessment of Pharmacodynamic Effects Following Oral Administration of Crushed Morphine Sulfate and Naltrexone Hydrochloride Extended-Release Capsules Compared with Crushed Morphine Sulfate Controlled-Release Tablets and Placebo in Nondependent Recreational Opioid UsersBeatrice Setnik, Lynn R. Webster, Kenneth W. Sommerville et al.|Pain Medicine|2013Cited by 26
Intravenous abuse potential study of oxycodone alone or in combination with naltrexone in nondependent recreational opioid usersMiroslav Bačkonja, G Wolfram, Lynn R. Webster et al.|The American Journal of Drug and Alcohol Abuse|2016Cited by 15